Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
Figure 3: Changes in the number of viable cells in the BPC 157-treated tendon fibroblasts following the addition of growth hormone Figure 4: Changes in PCNA gene expression in the BPC 157-treated tendon fibroblasts following the addition of growth hormone 3) The results of the study conducted by the research team of Pervoic et
Why Choose Injections Over an Oral Supplement
Vogiatzoglou A, Oulhaj A, Smith AD, et al
Whether youre recovering from surgery, a torn tendon, or daily microtraumas from training, this peptide can help speed up recovery and reduce downtime
GENERAL INFORMATION